Abstract | PURPOSE: Direct hemoperfusion (DHP) with polymixin B-immobilized fiber (PMX) has been reported to be effective for patients with septic shock. The aim of this study was to clarify the mechanism of PMX-DHP effect on septic shock. METHODS: RESULTS: The survival rate of all patients at 28 days after ICU admission was 37.5% (9/24). The survival group showed significantly lower SOFA and APACHE-II scores than the nonsurvival group after PMX-DHP treatment (P = 0.008 and 0.028, respectively). The improved SOFA score group showed a better survival rate than the nonimproved SOFA score group (71.4% versus 23.5%, P = 0.028). Plasma ANA level significantly decreased after PMX-DHP treatment both in the improved SOFA score group and in the survival group. The level of 2-AG, however, showed no significant change in either group. CONCLUSION:
|
Authors | Shinji Kohro, Hitoshi Imaizumi, Michiaki Yamakage, Yoshiki Masuda, Akiyoshi Namiki, Yasuhumi Asai, Ikuo Maruyama |
Journal | Journal of anesthesia
(J Anesth)
Vol. 20
Issue 1
Pg. 11-6
( 2006)
ISSN: 0913-8668 [Print] Japan |
PMID | 16421670
(Publication Type: Journal Article)
|
Chemical References |
- Arachidonic Acids
- Endocannabinoids
- Polyunsaturated Alkamides
- Transforming Growth Factor beta
- Polymyxin B
- Calcitonin Gene-Related Peptide
- anandamide
|
Topics |
- APACHE
- Adult
- Aged
- Arachidonic Acids
(blood, isolation & purification)
- Calcitonin Gene-Related Peptide
(blood)
- Endocannabinoids
- Female
- Hemoperfusion
(methods)
- Humans
- Male
- Middle Aged
- Multiple Organ Failure
(mortality, therapy)
- Polymyxin B
(administration & dosage)
- Polyunsaturated Alkamides
- Prognosis
- Prospective Studies
- Shock, Septic
(mortality, therapy)
- Survival Rate
- Transforming Growth Factor beta
(blood)
|